Last reviewed · How we verify
NCT05436860
PreDEA Study, Prevention in Emergency / Acceptance Departments: the Case of Hepatic Steatosis
trial testing liver ultrasound in Hepatic Steatosis in 20,189 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | University of L'Aquila |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20,189 |
| Start date | 1 July 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 1 July 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- liver ultrasound
Conditions studied
- Hepatic Steatosis — all drugs for Hepatic Steatosis →
Sponsor
University of L'Aquila
Who can join
18 and older, any sex, with Hepatic Steatosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our study aims to evaluate whether the Emergency Department (PS) can support the health system to improve the prevention and management of chronic inflammatory diseases and ensure actions aimed at screening, raising awareness and informing the population. Specifically, the determination of the prevalence of a widely diffused pathology such as fatty liver disease aims to be the precursor of future pilot studies aimed at evaluating the advantages and critical issues of the PS as a prevention tool.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05436860
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hepatic Steatosis
Currently open trials in the same condition.
- NCT07481734 — Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study) · Phase 2 · recruiting
- NCT06940375 — Incidence of Liver Disease-Related Outcomes in People With HIV · recruiting
- NCT07192159 — Quantitative Ultrasound(DeepUSFF) vs MRI-PDFF for Liver Fat Assessment in MASLD · NA · recruiting
- NCT06891365 — Multiple Dose Study for a New Medication to Potentially Treat Liver Diseases · Phase 1 · recruiting
- NCT06694012 — Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2 · recruiting
Other University of L'Aquila trials
Trials by the same sponsor.
- NCT06525987 — Telecoached Exercise Intervention for Connectivity Enhancement in Small Vessel Disease (TELECONNECT-SVD) · NA · recruiting
- NCT06823466 — Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants · recruiting
- NCT05816213 — Point-of-care Low-field MRI in Acute Stroke · not yet recruiting
- NCT06958874 — Adjunctive Effect of Erythritol on Pocket Closure Rates · NA · recruiting
- NCT06790459 — Effects of the Ultra-low Frequencies TENS on the Arousal Circuits · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05436860 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of L'Aquila
- Last refreshed: 5 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05436860.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing